돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 658생성일: 2026년 10월 25일

Morpholine → 4-(6-Bromopyridin-3-yl)morpholine

https://huagongshe.com/reaction/658

반응식

참여 물질

역할이름HCID투입량
반응물MorpholineHCID 8083—
반응물2-Bromo-5-iodopyridineHCID 4738271—
시약Sodium t-butoxideHCID 23676156—
촉매1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
촉매Bis(dibenzylideneacetone)palladiumHCID 9811564—
용매TolueneHCID 1140—
생성물4-(6-Bromopyridin-3-yl)morpholineHCID 2309213156.05%

반응 조건

온도20 °C

반응 단계

Pd2(dba)3 (0.564 g, 0.62 mmol) was added to 2-bromo-5-iodopyridine (5.00 g, 17.61 mmol), morpholine (1.541 mL, 17.61 mmol), sodium tert-butoxide (4.23 g, 44.03 mmol) and Xantphos (1.019 g, 1.76 mmol) in toluene (200 mL) at 20°C. The resulting solution was stirred at r.t. for 3 days (as the reaction was started on a Friday). Complete. The reaction mixture was diluted with EtOAc (100 mL), and washed sequentially with water (100 mL) and saturated brine (100 mL). The organic layer was dried with MgSO4, filtered and evaporated to afford crude product. The crude product was purified by flash silica chromatography, elution gradient 0 to 100% (EtOAc:MeOH - 10:1) in heptane. Pure fractions were evaporated to dryness LCMS indicated some di-substituted product present. Triturated in heptane:EtOAc, filtered and dried to afford 4-(6-bromopyridin-3-yl)morpholine (2.400 g, 56.1 %) as a beige solid.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-e0d3875cf2584a84afda6341abdff6dc
출처 메모750 AstraZeneca ELN dataset